Alumis (ALMS) News Today $7.66 -0.13 (-1.67%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Geode Capital Management LLC Purchases Shares of 305,680 Alumis Inc. (NASDAQ:ALMS)Geode Capital Management LLC bought a new stake in shares of Alumis Inc. (NASDAQ:ALMS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 305,680 shares of the company's stock, valued at approximately $3,266,000. GeodJanuary 7, 2025 | marketbeat.comAlumis Inc.’s ESK-001: A Promising TYK2 Inhibitor with Blockbuster PotentialJanuary 6, 2025 | markets.businessinsider.comAlumis' (ALMS) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $26.00 price target on shares of Alumis in a research report on Monday.January 6, 2025 | marketbeat.comState Street Corp Makes New Investment in Alumis Inc. (NASDAQ:ALMS)State Street Corp purchased a new stake in Alumis Inc. (NASDAQ:ALMS - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 81,059 shares of the company's stock, valued at approximately $866,000. State Street CJanuary 3, 2025 | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Receives Average Rating of "Buy" from BrokeragesShares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have earned a consensus rating of "Buy" from the eight analysts that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the cDecember 31, 2024 | marketbeat.comOwning 32% shares,hedge funds owners seem interested in Alumis Inc. (NASDAQ:ALMS),December 28, 2024 | uk.finance.yahoo.comStifel Financial Corp Invests $931,000 in Alumis Inc. (NASDAQ:ALMS)Stifel Financial Corp purchased a new stake in Alumis Inc. (NASDAQ:ALMS - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 87,185 shares of the company's stock, valued at apprDecember 24, 2024 | marketbeat.comAlumis announces Phase 1 data for CNS penetrant TYK2 inhibitor, A-005December 20, 2024 | markets.businessinsider.comAlumis (NASDAQ:ALMS) Given "Buy" Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $26.00 price objective on shares of Alumis in a research report on Friday.December 20, 2024 | marketbeat.comAlumis Announces Positive Phase 1 Data for CNS Penetrant TYK2 Inhibitor, A-005December 19, 2024 | markets.businessinsider.comCharles Schwab Investment Management Inc. Takes $1.16 Million Position in Alumis Inc. (NASDAQ:ALMS)Charles Schwab Investment Management Inc. purchased a new position in Alumis Inc. (NASDAQ:ALMS - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 108,593 shares of the company's stock, valued at approximately $1,160December 18, 2024 | marketbeat.comAlumis Inc.'s (NASDAQ:ALMS) Lock-Up Period Set To Expire on December 25thAlumis' (NASDAQ:ALMS - Get Free Report) lock-up period is set to expire on Wednesday, December 25th. Alumis had issued 13,125,000 shares in its IPO on June 28th. The total size of the offering was $210,000,000 based on an initial share price of $16.00. After the expiration of Alumis' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.December 18, 2024 | marketbeat.comLilly tops Morgan Stanley's biopharma pick list for 2025December 8, 2024 | msn.comAlumis Inc. (NASDAQ:ALMS) Given Average Rating of "Buy" by AnalystsShares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have earned a consensus rating of "Buy" from the eight analysts that are currently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to theDecember 6, 2024 | marketbeat.comSamsara BioCapital LLC Makes New $34.89 Million Investment in Alumis Inc. (NASDAQ:ALMS)Samsara BioCapital LLC acquired a new position in Alumis Inc. (NASDAQ:ALMS - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,266,498 shares of the company's stock, valued at appDecember 5, 2024 | marketbeat.comAlumis: A Best-In-Class TYK2 InhibitorNovember 28, 2024 | seekingalpha.comAlumis Inc. (NASDAQ:ALMS) Shares Sold by Ally Bridge Group NY LLCAlly Bridge Group NY LLC cut its stake in shares of Alumis Inc. (NASDAQ:ALMS - Free Report) by 32.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 418,416 shares of the company's stock after selling 200,334November 28, 2024 | marketbeat.comBuy Rating for Alumis Inc. Driven by Promising ESK-001 Clinical Results and Reduced CompetitionNovember 22, 2024 | markets.businessinsider.comAlumis Inc.: Promising Clinical Advancements and Strategic Positioning Drive Buy RatingNovember 20, 2024 | markets.businessinsider.comHC Wainwright Has Positive Outlook of Alumis FY2024 EarningsAlumis Inc. (NASDAQ:ALMS - Free Report) - Research analysts at HC Wainwright lifted their FY2024 earnings estimates for Alumis in a research report issued on Thursday, November 14th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($9.75) per share for the yeaNovember 18, 2024 | marketbeat.comFY2024 EPS Estimates for Alumis Reduced by Leerink PartnrsAlumis Inc. (NASDAQ:ALMS - Free Report) - Analysts at Leerink Partnrs cut their FY2024 earnings per share estimates for shares of Alumis in a note issued to investors on Wednesday, November 13th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($9.55) per shaNovember 18, 2024 | marketbeat.comAlumis Inc.: Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent AchievementsNovember 18, 2024 | finanznachrichten.deAlumis Inc. Reports Q3 2024 Financial Results and Advances Clinical ProgramsNovember 16, 2024 | markets.businessinsider.comAlumis Inc. Reports Q3 2024 Financial Results and Advances Clinical ProgramsNovember 16, 2024 | tipranks.comAlumis price target lowered to $26 from $30 at H.C. WainwrightNovember 15, 2024 | markets.businessinsider.comAlumis Inc. (NASDAQ:ALMS) is Towerview LLC's 8th Largest PositionTowerview LLC boosted its stake in shares of Alumis Inc. (NASDAQ:ALMS - Free Report) by 22.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 380,000 shares of the company's stock after acquiring an additional 70,000 shares dNovember 14, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Given Overweight Rating at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Alumis in a research note on Thursday.November 14, 2024 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Alumis (NASDAQ:ALMS) Stock PriceHC Wainwright cut their target price on Alumis from $30.00 to $26.00 and set a "buy" rating for the company in a research note on Thursday.November 14, 2024 | marketbeat.comAlumis Reports Third Quarter 2024 Financial Results and Highlights Recent AchievementsNovember 13, 2024 | globenewswire.comAlumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Buy" from AnalystsAlumis Inc. (NASDAQ:ALMS - Get Free Report) has been given a consensus rating of "Buy" by the eight analysts that are covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company.November 11, 2024 | marketbeat.comAlumis to Participate in Guggenheim's Inaugural Healthcare Innovation ConferenceNovember 4, 2024 | markets.businessinsider.comAlumis initiated with an Outperform at BairdNovember 1, 2024 | markets.businessinsider.comPromising Prospects for Alumis Inc.’s TYK2 Inhibitors: Analyst Recommends Buy RatingNovember 1, 2024 | markets.businessinsider.comAlumis (NASDAQ:ALMS) Rating Increased to Strong-Buy at Baird R WBaird R W raised Alumis to a "strong-buy" rating in a research report on Thursday.November 1, 2024 | marketbeat.comBaird Initiates Coverage of Alumis (ALMS) with Outperform RecommendationNovember 1, 2024 | msn.comThis Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayOctober 31, 2024 | benzinga.comAlumis (NASDAQ:ALMS) Coverage Initiated at Robert W. BairdRobert W. Baird initiated coverage on shares of Alumis in a research report on Thursday. They set an "outperform" rating and a $25.00 target price on the stock.October 31, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Trading Down 4.5% - Time to Sell?Alumis (NASDAQ:ALMS) Shares Down 4.5% - What's Next?October 23, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Trading 3.1% Higher - What's Next?Alumis (NASDAQ:ALMS) Trading Up 3.1% - Here's What HappenedOctober 21, 2024 | marketbeat.comHC Wainwright Estimates Alumis' Q3 Earnings (NASDAQ:ALMS)Alumis Inc. (NASDAQ:ALMS - Free Report) - Investment analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Alumis in a note issued to investors on Thursday, October 17th. HC Wainwright analyst M. Kapoor expects that the company will earn ($2.27) per shareOctober 21, 2024 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Alumis (ALMS) with Buy RecommendationOctober 17, 2024 | msn.comAlumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock UpsideOctober 17, 2024 | benzinga.comAlumis (NASDAQ:ALMS) Shares Gap Up - Time to Buy?Alumis (NASDAQ:ALMS) Shares Gap Up - Here's WhyOctober 17, 2024 | marketbeat.comAlumis Inc. (NASDAQ:ALMS) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have been assigned a consensus recommendation of "Buy" from the five brokerages that are covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to theOctober 17, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Receives New Coverage from Analysts at HC WainwrightHC Wainwright began coverage on shares of Alumis in a research report on Thursday. They issued a "buy" rating and a $30.00 price target for the company.October 17, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Stock Price Down 2.6% - What's Next?Alumis (NASDAQ:ALMS) Shares Down 2.6% - Should You Sell?October 16, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Shares Up 6.9% - What's Next?Alumis (NASDAQ:ALMS) Trading 6.9% Higher - Time to Buy?October 15, 2024 | marketbeat.comMillennium Management LLC Buys Shares of 253,820 Alumis Inc. (NASDAQ:ALMS)Millennium Management LLC bought a new position in shares of Alumis Inc. (NASDAQ:ALMS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 253,820 shares of the company's stock, valued at approxiOctober 15, 2024 | marketbeat.comAlumis (NASDAQ:ALMS) Stock Quotes, Forecast and News SummaryOctober 10, 2024 | benzinga.comJim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'October 9, 2024 | benzinga.com Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address ALMS Media Mentions By Week ALMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALMS News Sentiment▼0.000.44▲Average Medical News Sentiment ALMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALMS Articles This Week▼03▲ALMS Articles Average Week Get Alumis News Delivered to You Automatically Sign up to receive the latest news and ratings for ALMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARDX News NRIX News KNSA News RCUS News MRVI News OCUL News ARVN News CALT News DAWN News SPRY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALMS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alumis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alumis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALMS Stock Alerts